12/20/2024
4:00 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/19/2024
7:30 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/10/2024
4:15 PM | Del Giudice Matthew Paul (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | MacPherson Edward Clouston (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
4:15 PM | MIRA Pharmaceuticals (Issuer)
Whalen Matthew Pratt (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
7:45 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
3:15 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
4:58 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
10/21/2024
6:00 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
4:20 PM | MIRA Pharmaceuticals (Filer)
| Form 424B5 | |
09/27/2024
3:45 PM | MIRA Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/12/2024
3:30 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
3:01 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/06/2024
3:38 PM | McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Subject)
| Form 144/A | |
09/04/2024
7:20 PM | McNulty Brian Patrick (Reporting)
MIRA Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2024
11:15 PM | MIRA Pharmaceuticals (Filer)
| Form EFFECT | |
08/12/2024
7:37 AM | MIRA Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/08/2024
7:54 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/26/2024
3:49 PM | MIRA Pharmaceuticals (Filer)
| Form DEF 14A | |
07/26/2024
3:55 PM | MIRA Pharmaceuticals (Filer)
| Form DEFA14A | |
07/24/2024
3:07 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
4:12 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2024
4:00 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2024
3:30 PM | MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
5:00 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
7:30 AM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/22/2024
4:42 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
6:00 AM | MIRA Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/27/2024
4:53 PM | Del Giudice Matthew Paul (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | MacPherson Edward Clouston (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | Jerman Michael Allen (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | MIRA Pharmaceuticals (Issuer)
Yanez Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
4:53 PM | Aminov Erez (Reporting)
MIRA Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
6:00 PM | MIRA Pharmaceuticals (Issuer)
Shekhat Denil Nanji (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/13/2024
3:30 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2024
3:45 PM | MIRA Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
